The involvement of VEGF receptors and MAPK in the cannabinoid potentiation of Ca2+ flux into N18TG2 neuroblastoma cells

Molecular Brain Research

Volumn 120, Issue 2, 2004, Pages 138-144

  Rubovitch, Vardit ^a   Gafni, Mikhal ^a   Sarne, Yosef ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Ca2+ uptake; Cannabinoid receptors; ERK1 2; Receptor tyrosin kinase; Voltage dependent calcium channels

Indexed keywords

CANNABINOID RECEPTOR AGONIST; CHELERYTHRINE; DEACETYLLEVONANTRADOL; METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; OXINDOLE; PHENANTHROLINE; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; VASCULOTROPIN RECEPTOR;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; TRANSACTIVATION;

EID: 1642450673     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2003.10.012     Document Type: Article

References (54)

1. Annie T. SU5416 is a potent inhibitor of the vascular endothelial growth factor receptor (Flk1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res. 59:1999;99-106.
2. Assi A.A., Carney S., McCollum L., Norford D., Howlett A. Cannabinoid agonists and Gi/o-mediated cellular signal transduction mechanisms. ICRS 12th Annual Symposium on the Cannabinoids. 2002;85.
3. Bash R.R., Gafni V.M., Sarne Y. The stimulatory effect of cannabinoids on calcium uptake is mediated by Gs GTP-binding proteins and cAMP formation. Neurosignals. 2003;39-44.
4. Belcheva M.M., Coscia C.J. Diversity of G protein-coupled receptor signaling pathways to ERK/MAP kinase. Neurosignals. 11:2002;34-44.
5. Berdyshev E.V., Schmid P.C., Krebsbach R.J., Hillard C.J., Huang C., Chen N., Dong Z., Schmid H.H. Cannabinoid-receptor-independent cell signalling by N-acylethanolamines. Biochem. J. 360:2001;67-75.
6. Bouaboula M., Poinot-Chazel C., Marchand J., Canat X., Bourrie B., Rinaldi-Carmona M., Calandra B., Le Fur G., Casellas P. Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur. J. Biochem. 237:1996;704-711.
7. Bouaboula M., Bianchini L., McKenzie F.R., Pouyssegur J., Casellas P. Cannabinoid receptor CB1 activates the Na+/H+ exchanger NHE-1 isoform via Gi-mediated mitogen activated protein kinase signaling transduction pathways. FEBS Lett. 449:1999;61-65.
8. Brandes R.P., Popp R., Ott G., Bredenkotter D., Wallner C., Busse R., Fleming I. The extracellular regulated (ERK)1/2 mediate cannabinoid-induced inhibition of gap junctional communication in endothelial cells. Br. J. Pharmacol. 136:2002;709-716.
9. Cai H., Smola U., Wixler V., Eisenmann-Tappe I., Diaz-Meco M.T., Moscat J., Rapp U., Cooper G.M. Role of diacylglycerol-regulated protein kinase C isotypes in growth factor activation of the Raf-1 protein kinase. Mol. Cell Biol. 17:1997;732-741.
10. Carpenter G. EGF receptor transactivation mediated by the proteolytic production of EGF-like agonists. Sci. Signal Transduct. Knowl. Environ. 2000:2000;E1.
11. Chan G.C., Hinds T.R., Impey S., Storm D.R. Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol. J. Neurosci. 18:1998;5322-5332.
12. Daub H., Weiss F.U., Wallasch C., Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature. 379:1996;557-560.
13. Davis W.M., Moreton J.E., King W.T., Pace H.B. Marihuana on locomotor activity: biphasic effect and tolerance development. PG-29-35. Res. Commun. Chem. Pathol. Pharmacol. 3:1972;29-35.
14. Derkinderen P., Ledent C., Parmentier M., Girault J.A. Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus. J. Neurochem. 77:2001;957-960.
15. Dziema H., Obrietan K. PACAP potentiates L-type calcium channel conductance in suprachiasmatic nucleus neurons by activating the MAPK pathway. J. Neurophysiol. 88:2002;1374-1386.
16. M.D. Ehlers, G.J. Augustine, Cell signalling. Calmodulin at the channel gate, Nature, 399 (1999) 105, 107-108.
17. Ekinci F.J., Malik K.U., Shea T.B. Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to beta-amyloid. MAP kinase mediates beta-amyloid-induced neurodegeneration. J. Biol. Chem. 274:1999;30322-30327.
18. Fimiani C., Mattocks D., Cavani F., Salzet M., Deutsch D.G., Pryor S., Bilfinger T.V., Stefano G.B. Morphine and anandamide stimulate intracellular calcium transients in human arterial endothelial cells: coupling to nitric oxide release. Cell Signal. 11:1999;189-193.
19. Fitzgerald E.M. Regulation of voltage-dependent calcium channels in rat sensory neurones involves a Ras-mitogen-activated protein kinase pathway. J. Physiol. 527(Pt. 3):2000;433-444.
20. Galve-Roperh I., Sanchez C., Cortes M.L., del Pulgar T.G., Izquierdo M., Guzman M. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat. Med. 6:2000;313-319.
21. Galve-Roperh I., Rueda D., Gomez del Pulgar T., Velasco G., Guzman M. Mechanism of extracellular signal-regulated kinase activation by the CB(1) cannabinoid receptor. Mol. Pharmacol. 62:2002;1385-1392.
22. Gebremedhin D., Lange A.R., Campbell W.B., Hillard C.J., Harder D.R. Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. Am. J. Physiol. 276:1999;H2085-H2093.
23. Glass M., Felder C.C. Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J. Neurosci. 17:1997;5327-5333.
24. Gutkind J.S. Cell growth control by G protein-coupled receptors: from signal transduction to signal integration. Oncogene. 17:1998;1331-1342.
25. Hampson R.E., Mu J., Deadwyler S.A. Cannabinoid and kappa opioid receptors reduce potassium K current via activation of G(s) proteins in cultured hippocampal neurons. J. Neurophysiol. 84:2000;2356-2364.
26. Hawes B.E., Luttrell L.M., van Biesen T., Lefkowitz R.J. Phosphatidylinositol 3-kinase is an early intermediate in the G beta gamma-mediated mitogen-activated protein kinase signaling pathway. J. Biol. Chem. 271:1996;12133-12136.
27. Heidkamp M.C., Bayer A.L., Martin J.L., Samarel A.M. Differential activation of mitogen-activated protein kinase cascades and apoptosis by protein kinase C epsilon and delta in neonatal rat ventricular myocytes. Circ. Res. 89:2001;882-890.
28. Ho R., Ortiz D., Shea T.B. Amyloid-beta promotes calcium influx and neurodegeneration via stimulation of L voltage-sensitive calcium channels rather than NMDA channels in cultured neurons. J. Alzheimer's Dis. 3:2001;479-483.
29. Howlett A.C., Qualy J.M., Khachatrian L.L. Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29:1986;307-313.
30. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., Pertwee R.G. International union of pharmacology: XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54:2002;161-202.
31. Kamp T.J., Hell J.W. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ. Res. 87:2000;1095-1102.
32. Lev S., Moreno H., Martinez R., Canoll P., Peles E., Musacchio J.M., Plowman G.D., Rudy B., Schlessinger J. Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature. 376:1995;737-745.
33. Levitzki A., Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science. 267:1995;1782-1788.
34. Lopez-Ilasaca M., Gutkind J.S., Wetzker R. Phosphoinositide 3-kinase gamma is a mediator of Gbetagamma-dependent Jun kinase activation. J. Biol. Chem. 273:1998;2505-2508.
35. Mackie K., Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. U. S. A. 89:1992;3825-3829.
36. Mackie K., Lai Y., Westenbroek R., Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15:1995;6552-6561.
37. Perets T., Blumenstein Y., Shistik E., Lotan I., Dascal N. A potential site of functional modulation by protein kinase A in the cardiac Ca2+ channel alpha 1C subunit. FEBS Lett. 384:1996;189-192.
38. Pierce K.L., Tohgo A., Ahn S., Field M.E., Luttrell L.M., Lefkowitz R.J. Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding. J. Biol. Chem. 276:2001;23155-23160.
39. Prenzel N., Zwick E., Daub H., Leserer M., Abraham R., Wallasch C., Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature. 402:1999;884-888.
40. Rubino T., Vigano D., Zippel R., Parolaro D. Map kinases pathway plays a role in cannabinoid tolerance. INRC, 33th International Narcotics Research Conference. 2002;30.
41. Rubovitch V., Gafni M., Sarne Y. The cannabinoid agonist DALN positively modulates L-type voltage-dependent calcium channels in N18TG2 neuroblastoma cells. Mol. Brain Res. 101:2002;93-102.
42. Rueda D., Galve-Roperh I., Haro A., Guzman M. The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol. Pharmacol. 58:2000;814-820.
43. Sanudo-Pena M.C., Romero J., Seale G.E., Fernandez-Ruiz J.J., Walker J.M. Activational role of cannabinoids on movement. Eur. J. Pharmacol. 391:2000;269-274.
44. Schonwasser D.C., Marais R.M., Marshall C.J., Parker P.J. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol. Cell Biol. 18:1998;790-798.
45. Shistik E., Keren-Raifman T., Idelson G.H., Blumenstein Y., Dascal N., Ivanina T. The N terminus of the cardiac L-type Ca(2+) channel alpha(1C) subunit. The initial segment is ubiquitous and crucial for protein kinase C modulation, but is not directly phosphorylated. J. Biol. Chem. 274:1999;31145-31149.
46. Singh K., Xiao L., Remondino A., Sawyer D.B., Colucci W.S. Adrenergic regulation of cardiac myocyte apoptosis. J. Cell. Physiol. 189:2001;257-265.
47. Stefano G.B., Rialas C.M., Deutsch D.G., Salzet M. Anandamide amidase inhibition enhances anandamide-stimulated nitric oxide release in invertebrate neural tissues. Brain Res. 793:1998;341-345.
48. Sugiura T., Kodaka T., Kondo S., Tonegawa T., Nakane S., Kishimoto S., Yamashita A., Waku K. 2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma×glioma hybrid NG108-15 cells. Biochem. Biophys. Res. Commun. 229:1996;58-64.
49. Sulcova E., Mechoulam R., Fride E. Biphasic effects of anandamide. Pharmacol. Biochem. Behav. 59:1998;347-352.
50. Sun L., Tran N., Tang F., App H., Hirth P., McMahon G., Tang C. Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. J. Med. Chem. 41:1998;2588-2603.
51. Troller U., Zeidman R., Svensson K., Larsson C. A PKCbeta isoform mediates phorbol ester-induced activation of Erk1/2 and expression of neuronal differentiation genes in neuroblastoma cells. FEBS Lett. 508:2001;126-130.
52. Twitchell W., Brown S., Mackie K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 78:1997;43-50.
53. Velarde V., Jenkins A.J., Christopher J., Lyons T.J., Jaffa A.A. Activation of MAPK by modified low-density lipoproteins in vascular smooth muscle cells. J. Appl. Physiol. 91:2001;1412-1420.
54. Wang H., Ubl J.J., Stricker R., Reiser G. Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. Am. J. Physiol., Cell Physiol. 283:2002;C1351-C1364.